Seladelpar Lysine Patent Expiration
Seladelpar Lysine was first introduced by Cymabay Therapeutics Inc
Seladelpar Lysine Patents
Given below is the list of patents protecting Seladelpar Lysine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Livdelzi | US10272058 | Treatment of intrahepatic cholestatic diseases | Mar 19, 2035 | Cymabay |
| Livdelzi | US11406611 | Treatment of intrahepatic cholestatic diseases | Mar 19, 2035 | Cymabay |
| Livdelzi | US11596614 | Treatment of intrahepatic cholestatic diseases | Mar 19, 2035 | Cymabay |
| Livdelzi | US9486428 | Treatment of intrahepatic cholestatic diseases | Mar 19, 2035 | Cymabay |
| Livdelzi | US7709682 | Lysine salts of 4-((phenoxyalkyl)thio)-phenoxyacetic acid derivatives | Sep 13, 2026 | Cymabay |
| Livdelzi | US7301050 | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | Aug 02, 2025 | Cymabay |
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List